3 completed, 1 recruiting, 1 terminated. 5 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Recruiting 1, Terminated 1 |
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Troriluzole: new trials by email Literature Review of Troriluzole trials Research Report on Troriluzole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets Ipilimumab, Nivolumab, Troriluzole - Melanoma, Metastatic Melanoma | Phase 2 | Terminated | Dana-Farber Cancer Institute | 1 | 2021-06-30 | 2024-03-26 |
| A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma Temozolomide, Lomustine, Regorafenib - Glioblastoma | Phase 2 / Phase 3 | Recruiting | Global Coalition for Adaptive Research | 2250 | 2019-07-30 | 2026-11-02 |
| Study of BHV-4157 in Alzheimer's Disease troriluzole, Placebo oral capsule - Alzheimer Disease | Phase 2 | Completed | Biohaven Pharmaceuticals, Inc. | 350 | 2018-07-31 | 2023-12-06 |
| Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder Troriluzole, Placebo - Obsessive-Compulsive Disorder | Phase 2 / Phase 3 | Completed | Biohaven Pharmaceuticals, Inc. | 426 | 2017-12-19 | 2026-01-22 |
| Trial in Adult Participants With Spinocerebellar Ataxia (SCA) Troriluzole, Placebo - Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1 | Phase 2 / Phase 3 | Completed | Biohaven Pharmaceuticals, Inc. | 141 | 2016-12-15 | 2025-10-08 |
Alzheimer Disease (1) · Glioblastoma (1) · Melanoma (1) · Obsessive-Compulsive Disorder (1) · Recurrence (1) · Spinocerebellar Ataxias (1)
Biohaven Pharmaceuticals, Inc. (3) · Dana-Farber Cancer Institute (1) · Global Coalition for Adaptive Research (1)
United States (5) · Australia (1) · Canada (1) · France (1) · Germany (1) · Switzerland (1)
Ann W Silk, MD, MS (1) · Tim Cloughesy, MD (1)
PMID 34115419, PMID 38773224, PMID 39462179, PMID 40317057, PMID 41980234